📣 VC round data is live. Check it out!
- Public Comps
- Wacker Chemie
Wacker Chemie Valuation Multiples
Discover Wacker Chemie's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Luberef, UPL, Croda International, SOL and more.
Wacker Chemie Overview
About Wacker Chemie
Wacker Chemie AG manufactures and sells chemicals and silicon-based products. The firm organizes itself into four segments based on product type. The Wacker Silicones segment, which generates the majority revenue of any segment, sells silicon- and methanol-based products, including durable insulators, lubricants, and sealants. The Wacker Polymers segment provides chemical binders and additives used in construction industry products. The Wacker Biosolutions segment sells chemicals to the pharmaceutical and agrochemical industries. The Wacker Polysilicon segment sells material for solar power and semiconductors. The majority of revenue comes from Europe, China, India, and South Korea.
Founded
1914
HQ

Employees
16.6K
Website
Sectors
Financials (LTM)
EV
$7B
Valuation Multiples
Start free trialWacker Chemie Financials
Wacker Chemie reported last 12-month revenue of $7B and EBITDA of $605M.
In the same LTM period, Wacker Chemie generated $922M in gross profit, $605M in EBITDA, and had net loss of ($525M).
Revenue (LTM)
Wacker Chemie P&L
In the most recent fiscal year, Wacker Chemie reported revenue of $6B and EBITDA of $497M.
Wacker Chemie is unprofitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 8%, and net margin of (15%).
Financial data powered by Morningstar, Inc.
Wacker Chemie Stock Performance
Wacker Chemie has current market cap of $6B, and enterprise value of $7B.
Market Cap Evolution
Wacker Chemie's stock price is $115.67.
Wacker Chemie share price decreased by 0.1% in the last 30 days, and increased by 61.7% in the last year.
Wacker Chemie has an EPS (earnings per share) of $-18.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7B | $6B | -0.1% | -0.1% | 16.5% | 61.7% | $-18.86 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWacker Chemie Valuation Multiples
Wacker Chemie trades at 1.0x EV/Revenue multiple, and 11.2x EV/EBITDA.
EV / Revenue (LTM)
Wacker Chemie Financial Valuation Multiples
As of June 2, 2026, Wacker Chemie has market cap of $6B and EV of $7B.
Wacker Chemie has a P/E ratio of (10.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Wacker Chemie Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Wacker Chemie Margins & Growth Rates
Wacker Chemie grew revenue by 4% and EBITDA by 52% in the last fiscal year.
In the most recent fiscal year, Wacker Chemie reported gross margin of 12%, EBITDA margin of 8%, and net margin of (15%).
Wacker Chemie Margins
Wacker Chemie Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Wacker Chemie Operational KPIs
Wacker Chemie's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Wacker Chemie's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Wacker Chemie's Rule of X is 22% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Wacker Chemie Competitors
Wacker Chemie competitors include Luberef, UPL, Croda International, SOL, Fuchs, Celanese, IMCD, Sumitomo Chemical, Arkema and Dottikon ES Holding.
Most Wacker Chemie public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.6x | 2.3x | 17.9x | 14.0x | |||
| 1.4x | 1.3x | 7.2x | 7.2x | |||
| 2.7x | 2.7x | 11.5x | 11.3x | |||
| 3.1x | 3.0x | 12.2x | 11.7x | |||
| 1.4x | 1.3x | 8.9x | 8.9x | |||
| 1.8x | 1.8x | 9.1x | 8.6x | |||
| 1.4x | 1.4x | 12.3x | 12.1x | |||
| 0.7x | 0.8x | 8.9x | 6.6x | |||
This data is available for Pro users. Sign up to see all Wacker Chemie competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Wacker Chemie
Wacker Chemie has acquired 2 companies to date.
Last acquisition by Wacker Chemie was on May 8th 2023. Wacker Chemie acquired ADL Biopharma for $110M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Wacker Chemie
| Description | ADL Biopharma is a León-based contract development and manufacturing organization in Spain focused on precision fermentation and synthesis of oral and sterile antibiotics. It operates one of Europe's largest industrial fermentation facilities, spanning 20,000 square meters, with capacities up to 100,000 liters per batch. The company conducts upstream and downstream processes for biologics like enzymes and probiotics, alongside API production for beta-lactams. ADL Biopharma supplies pharmaceutical firms such as Antibióticos S.A. and leverages a pilot plant for scaling novel molecules. With over 50 years of expertise since 1967, it benefits from León's biotech cluster and temperate climate. | Genopis is a Seongnam-headquartered contract development and manufacturing organization focused on plasmid DNA technologies for gene therapies, cell therapies, and mRNA vaccines. The company delivers end-to-end services from plasmid design and process development to cGMP manufacturing at scales ranging from milligrams for preclinical studies to kilograms for commercial production. Genopis operates advanced facilities in South Korea equipped for high-quality plasmid purification and analytics, supporting global biotech firms in accelerating clinical trials and market entry. Its expertise includes supercoiled plasmid production and endotoxin-free processes tailored for human applications. |
| HQ Country | ||
| HQ City | León | San Diego, CA |
| Deal Date | 8 May 2023 | 3 Feb 2021 |
| Valuation | $110M | $39M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Wacker Chemie acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Wacker Chemie
Wacker Chemie has invested in 1 company to date.
Latest investment by Wacker Chemie was on June 28th 2016. Wacker Chemie invested in 1366 Technologies in their $15M Series D round (EV/Revenue multiple available to Pro users).
Latest Investments by Wacker Chemie
| Description | 1366 Technologies is a Bedford-headquartered manufacturer of low-cost silicon wafers for photovoltaic solar cells. The company's Direct Wafer process reduces production costs by 50 percent, compatible with existing module lines. Founded in 2008, 1366 Tech shipped over 100 megawatts of wafers before its 2020 acquisition by a strategic buyer, advancing U.S. solar manufacturing. |
| HQ Country | |
| HQ City | - |
| Deal Date | 28 Jun 2016 |
| Round | Series D |
| Raised | $15M |
| Investors | Wacker Chemie |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Wacker Chemie investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Wacker Chemie
| When was Wacker Chemie founded? | Wacker Chemie was founded in 1914. |
| Where is Wacker Chemie headquartered? | Wacker Chemie is headquartered in Germany. |
| How many employees does Wacker Chemie have? | As of today, Wacker Chemie has over 16K employees. |
| Is Wacker Chemie publicly listed? | Yes, Wacker Chemie is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Wacker Chemie? | Wacker Chemie trades under WCH ticker. |
| When did Wacker Chemie go public? | Wacker Chemie went public in 2006. |
| Who are competitors of Wacker Chemie? | Wacker Chemie main competitors include Luberef, UPL, Croda International, SOL, Fuchs, Celanese, IMCD, Sumitomo Chemical, Arkema, Dottikon ES Holding. |
| What is the current market cap of Wacker Chemie? | Wacker Chemie's current market cap is $6B. |
| What is the current revenue of Wacker Chemie? | Wacker Chemie's last 12 months revenue is $7B. |
| What is the current revenue growth of Wacker Chemie? | Wacker Chemie revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Wacker Chemie? | Current revenue multiple of Wacker Chemie is 1.0x. |
| What is the current EBITDA of Wacker Chemie? | Wacker Chemie's last 12 months EBITDA is $605M. |
| What is Wacker Chemie's EBITDA margin? | Wacker Chemie's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Wacker Chemie? | Current EBITDA multiple of Wacker Chemie is 11.2x. |
| What is the current FCF of Wacker Chemie? | Wacker Chemie's last 12 months FCF is $2M. |
| What is Wacker Chemie's FCF margin? | Wacker Chemie's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Wacker Chemie? | Current FCF multiple of Wacker Chemie is 2938.5x. |
| How many companies Wacker Chemie has acquired to date? | As of June 2026, Wacker Chemie has acquired 2 companies. |
| What was the largest acquisition by Wacker Chemie? | $110M acquisition of ADL Biopharma on 8th May 2023 was the largest M&A Wacker Chemie has done to date. |
| What companies Wacker Chemie acquired? | Wacker Chemie acquired ADL Biopharma and Genopis. |
| In how many companies Wacker Chemie has invested to date? | As of June 2026, Wacker Chemie has invested in 1 company. |
| What was the last Wacker Chemie investment? | On 28th June 2016 Wacker Chemie invested in 1366 Technologies, participating in a $15M Series D round. |
| In what companies Wacker Chemie invested in? | Wacker Chemie invested in 1366 Technologies. |
See public comps similar to Wacker Chemie
Lists including Wacker Chemie
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

